• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Acute dyspnea, subfebrile temperatures and chills in a patient with multiple myeloma].

作者信息

Merz M, Herth I, Brandt J, Hundemer M, Neben K, Goldschmidt H, Heußel C P

机构信息

Medizinische Klinik V, Abteilung für Hämatologie, Onkologie und Rheumatologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland,

出版信息

Med Klin Intensivmed Notfmed. 2014 Mar;109(2):137-40. doi: 10.1007/s00063-013-0298-z. Epub 2013 Oct 23.

DOI:10.1007/s00063-013-0298-z
PMID:24145709
Abstract
摘要

相似文献

1
[Acute dyspnea, subfebrile temperatures and chills in a patient with multiple myeloma].[一名多发性骨髓瘤患者出现急性呼吸困难、低热和寒战]
Med Klin Intensivmed Notfmed. 2014 Mar;109(2):137-40. doi: 10.1007/s00063-013-0298-z. Epub 2013 Oct 23.
2
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.多柔比星脂质体注射液、小剂量地塞米松和来那度胺治疗初诊多发性骨髓瘤的 II 期研究。
Am J Hematol. 2014 Jan;89(1):62-7. doi: 10.1002/ajh.23587.
3
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.沙利度胺、克拉霉素、来那度胺及地塞米松疗法用于新诊断的有症状多发性骨髓瘤
Leuk Lymphoma. 2014 Dec;55(12):2842-9. doi: 10.3109/10428194.2014.896005. Epub 2014 Mar 25.
4
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.环磷酰胺用于干细胞动员可克服来那度胺治疗对多发性骨髓瘤干细胞采集的抑制作用。
Biol Blood Marrow Transplant. 2008 Jul;14(7):795-8. doi: 10.1016/j.bbmt.2008.04.008.
5
Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up.在ECOG-ACRIN E4A03随机临床试验中，新诊断的多发性骨髓瘤患者接受来那度胺联合地塞米松治疗后早期进行自体干细胞移植的结果：长期随访
Blood Cancer J. 2016 Sep 2;6(9):e466. doi: 10.1038/bcj.2016.68.
6
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.来那度胺联合化疗与自体移植，随后来那度胺联合泼尼松与来那度胺维持治疗多发性骨髓瘤患者：一项随机、多中心、3 期试验。
Lancet Oncol. 2015 Dec;16(16):1617-29. doi: 10.1016/S1470-2045(15)00389-7. Epub 2015 Nov 17.
7
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma.在多发性骨髓瘤中，VTD巩固治疗显著提高了VTD诱导及单次自体干细胞移植后的完全缓解率和疾病进展时间。
Leukemia. 2013 Nov;27(11):2242-4. doi: 10.1038/leu.2013.101. Epub 2013 Apr 5.
8
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.硼替佐米联合沙利度胺和地塞米松与沙利度胺和地塞米松作为新诊断多发性骨髓瘤患者双自体干细胞移植前诱导治疗和巩固治疗的比较：一项随机 3 期研究。
Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9.
9
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.在骨髓瘤患者中，来那度胺诱导治疗后干细胞动员受损。
Leukemia. 2008 Jun;22(6):1282-4. doi: 10.1038/sj.leu.2405100. Epub 2008 Jan 24.
10
Treatment of multiple myeloma in the targeted therapy era.靶向治疗时代的多发性骨髓瘤治疗
Ann Pharmacother. 2009 Feb;43(2):329-38. doi: 10.1345/aph.1L428. Epub 2009 Feb 3.

本文引用的文献

1
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit.血液科和移植病房呼吸道合胞病毒暴发的危险因素与控制。
Bone Marrow Transplant. 2013 Nov;48(12):1548-53. doi: 10.1038/bmt.2013.94. Epub 2013 Jul 1.
2
[Chronic critically ill patients from the perspective of hematologists/oncologists].血液科医生/肿瘤学家视角下的慢性危重症患者
Med Klin Intensivmed Notfmed. 2013 May;108(4):295-302. doi: 10.1007/s00063-012-0196-9. Epub 2013 Feb 28.
3
[Rheumatic patients in the intensive care unit].
[重症监护病房中的风湿性疾病患者]
Med Klin Intensivmed Notfmed. 2012 Jun;107(5):391-6. doi: 10.1007/s00063-011-0073-y. Epub 2012 Feb 2.
4
Acute lung toxicity related to pomalidomide.泊马度胺相关的急性肺毒性。
Chest. 2011 Aug;140(2):529-533. doi: 10.1378/chest.10-2082.
5
A case of lenalidomide-induced hypersensitivity pneumonitis.一例来那度胺诱发的过敏性肺炎。
Onkologie. 2010;33(5):249-52. doi: 10.1159/000305213. Epub 2010 Apr 13.
6
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.来那度胺联合高剂量地塞米松与来那度胺联合低剂量地塞米松作为初治多发性骨髓瘤的初始治疗：一项开放标签随机对照试验。
Lancet Oncol. 2010 Jan;11(1):29-37. doi: 10.1016/S1470-2045(09)70284-0. Epub 2009 Oct 21.
7
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.来那度胺和地塞米松治疗复发多发性骨髓瘤患者时，低分子量肝素对血栓栓塞并发症的有效预防作用
Ann Hematol. 2009 Jan;88(1):67-71. doi: 10.1007/s00277-008-0561-1. Epub 2008 Jul 31.
8
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.来那度胺联合地塞米松（Rev/Dex）用于新诊断骨髓瘤的联合治疗。
Blood. 2005 Dec 15;106(13):4050-3. doi: 10.1182/blood-2005-07-2817. Epub 2005 Aug 23.
9
Pneumonitis-associated hyperprocalcitoninemia.肺炎相关的高降钙素血症
Am J Med Sci. 1996 Jul;312(1):12-8. doi: 10.1097/00000441-199607000-00003.